BOPQFSYHHMTBMG-GDLZYMKVSA-N
C42H39F3N8O4 — CID 139529826
Data last refreshed: (MolForge compound catalog, from PubChem)
About BOPQFSYHHMTBMG-GDLZYMKVSA-N
BOPQFSYHHMTBMG-GDLZYMKVSA-N (PubChem CID 139529826) has the molecular formula C42H39F3N8O4 and a molecular weight of 776.82 g/mol. Its IUPAC name is 1-[[7-cyano-2-[3-[3-[[7-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]-2-(trifluoromethyl)pyrido[3,2-d]pyrimidin-4-yl]amino]-2-methylphenyl]-2-methylphenyl]-1,3-benzoxazol-5-yl]methyl]piperidine-4-carboxylic acid.
Molecular Properties
| Compound Name | BOPQFSYHHMTBMG-GDLZYMKVSA-N |
|---|---|
| PubChem CID | 139529826 |
| Molecular Formula | C42H39F3N8O4 |
| Molecular Weight | 776.82 g/mol |
| Exact Mass | 776.30 |
| IUPAC Name | 1-[[7-cyano-2-[3-[3-[[7-[[(3R)-3-hydroxypyrrolidin-1-yl]methyl]-2-(trifluoromethyl)pyrido[3,2-d]pyrimidin-4-yl]amino]-2-methylphenyl]-2-methylphenyl]-1,3-benzoxazol-5-yl]methyl]piperidine-4-carboxylic acid |
| SMILES | Cc1c(Nc2nc(C(F)(F)F)nc3cc(CN4CC[C@@H](O)C4)cnc23)cccc1-c1cccc(-c2nc3cc(CN4CCC(C(=O)O)CC4)cc(C#N)c3o2)c1C |
| InChI | InChI=1S/C42H39F3N8O4/c1-23-30(5-3-7-32(23)39-49-35-16-25(15-28(18-46)37(35)57-39)20-52-12-9-27(10-13-52)40(55)56)31-6-4-8-33(24(31)2)48-38-36-34(50-41(51-38)42(43,44)45)17-26(19-47-36)21-53-14-11-29(54)22-53/h3-8,15-17,19,27,29,54H,9-14,20-22H2,1-2H3,(H,55,56)(H,48,50,51)/t29-/m1/s1 |
| InChIKey | BOPQFSYHHMTBMG-GDLZYMKVSA-N |
| XLogP | 7.61 |
| TPSA | 164.53 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 57 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 776.82 |
| LogP ≤ 5 | 7.61 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139529826 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.